BTIG Research reiterated coverage on Evolent Health with a new price target

12/3/24 7:52:53 AM ET

Other Consumer Services

Consumer Discretionary

BTIG Research reiterated coverage of Evolent Health with a rating of Buy and set a new price target of $29.00 from $36.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$EVH

Date	Price Target	Rating	Analyst
1/10/2025	$15.00	Buy	Needham
12/3/2024	$36.00 → $29.00	Buy	BTIG Research
11/8/2024	$38.00 → $16.00	Overweight → Equal-Weight	Stephens
10/11/2024	$35.00	Overweight	KeyBanc Capital Markets
8/9/2024	$28.00 → $33.00	Hold → Buy	Truist
4/22/2024	$40.00	Buy	Citigroup
3/1/2024	$45.00	Outperform	Oppenheimer
1/3/2024	$39.00	Overweight	Barclays